Darba 40mcg Injection

Darba 40 mcg Injection is a prescription erythropoiesis-stimulating agent (ESA) containing Darbepoetin alfa 40 mcg. It is used to treat anemia (low red blood cell count) associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in certain cancer patients. Darbepoetin alfa is a synthetic form of erythropoietin, a natural hormone produced by the kidneys that stimulates the bone marrow to produce red blood cells. By increasing red blood cell production, it helps improve oxygen delivery throughout the body, reducing symptoms such as fatigue, weakness, shortness of breath, dizziness, and reduced exercise tolerance. The injection is administered under the supervision of a healthcare professional, and regular monitoring of hemoglobin levels, blood pressure, and iron status is essential to ensure safe and effective treatment. Adequate iron, folic acid, and vitamin B12 levels are important for optimal response.

Darba 40 mcg Injection contains Darbepoetin alfa, a long-acting erythropoiesis-stimulating agent (ESA) that plays a vital role in the treatment of anemia associated with chronic kidney disease and chemotherapy. It works by mimicking the natural hormone erythropoietin, stimulating the bone marrow to produce more red blood cells. As red blood cell levels increase, oxygen transport throughout the body improves, helping relieve symptoms such as fatigue, weakness, dizziness, shortness of breath, and reduced physical endurance. Compared with conventional erythropoietin, Darbepoetin alfa has a longer half-life, allowing less frequent dosing while maintaining effective hemoglobin levels. Regular monitoring of hemoglobin is essential to avoid excessive increases, which may increase the risk of cardiovascular complications. Adequate iron, vitamin B12, and folate stores are also important to achieve the best therapeutic response. When used appropriately under medical supervision, Darba 40 mcg Injection improves quality of life, reduces the need for blood transfusions, and supports long-term anemia management.

Precaution

• Use only under medical supervision.
• Inform your doctor if you have uncontrolled high blood pressure, heart disease, stroke, seizures, blood clotting disorders, or allergies to darbepoetin alfa.
• Regular monitoring of hemoglobin levels and blood pressure is necessary during treatment.
• Ensure adequate iron, folic acid, and vitamin B12 levels, as deficiencies may reduce treatment effectiveness.
• Do not use this medicine to raise hemoglobin above the target level recommended by your doctor, as this may increase the risk of serious cardiovascular events.
• Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
• Tell your doctor about all medicines you are taking, including anticoagulants and other treatments for anemia.

Storage

• Store in a refrigerator at 2°C–8°C.
• Do not freeze.
• Keep the injection in its original carton to protect it from light.
• Do not shake the syringe or vial.
• Keep out of reach of children.
• Do not use after the expiry date or if the solution appears cloudy or contains particles.